Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A).

Source:http://linkedlifedata.com/resource/pubmed/id/9703181

Download in:

View as

General Info

PMID
9703181